Modulation of A1 adenosine receptor signaling by peroxynitrite

被引:11
|
作者
Giuntini, J [1 ]
Giusti, L [1 ]
Lucacchini, A [1 ]
Mazzoni, MR [1 ]
机构
[1] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, Pisa, Italy
关键词
A(1) adenosine receptors; G(i) proteins; nitric oxide; peroxynitrite; 3-morpholinosydnonimine;
D O I
10.1016/j.bcp.2003.08.045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitric oxide (NO) is a gaseous free radical involved in many pathophysiological processes. During oxidative stress, NO, its derivatives and adenosine are released. Considering adenosine neuroprotective role in the central nervous system (CNS) and toxicity of NO, we investigated the effect of a NO/peroxynitrite (ONOO-) donor, 3-morpholinosydnonimine (SIN-1), on A(1) adenosine receptor (A(1)AR) signaling pathway in rat cortical membranes. Membrane treatment with 0.5 mM SIN-1 for various periods of time (0-240 min) decreased specific binding of the radiolabeled A(1)AR agonist, [H-3]N-6-cyclohexyladenosine ([H-3]CHA), in a time-dependent manner, reaching the steady state after 120 min. The inhibitory effect of SIN-1 was concentration-dependent, with an EC50 value of 0.60 +/- 0.30 mM (N = 3). Membrane pre-incubation with the superoxide anion (O-2(.-)) scavenger superoxide dismutase (SOD) followed by SIN-1 addition, abolished SIN-1 inhibition of [H-3]CHA binding. Membrane treatment with 0.5 mM SIN-1 for 120 min caused a significant 2-fold increase of the K-D value for [H-3]CHA without changing the B-max value. Moreover, pre-incubation of membranes with A(1)AR agonists, CHA or N-6-(2-phenylisopropyl)-adenosine (R-PIA) before SIN-1 addition increased the inhibitory effect while the selective A(1)AR antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) had no activity. Membrane treatment with SIN-1 decreased receptor-stimulated guanosine 5'-O-(gamma[S-35]thio)triphosphate ([S-35]GTPgammaS) binding in a concentration-dependent manner. This treatment influenced [S-35]GTPgammaS binding affinity for A(1)AR activated G(i) proteins in cortical membranes. These findings suggest that ONOO- modulates A(1)AR signaling pathways by affecting receptor G(i) protein coupling. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 50 条
  • [21] Partial adenosine A1 receptor agonists
    Albrecht-Kuepper, B.
    PURINERGIC SIGNALLING, 2014, 10 (04) : 662 - 662
  • [22] Allosteric enhancers for A1 adenosine receptor
    Baraldi, Pier Giovanni
    Iaconinoto, Maria Antonietta
    Moorman, Allan R.
    Carrion, Maria Dora
    Cara, Carlota Lopez
    Preti, Delia
    Lopez, Olga Cruz
    Fruttarolo, Francesca
    Tabrizi, Mojgan Aghazadeh
    Romagnoli, Romeo
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (06) : 559 - 569
  • [23] Adenosine A1 receptor antagonists and the kidney
    Modlinger, PS
    Welch, WJ
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (05): : 497 - 502
  • [24] AMP Is an Adenosine A1 Receptor Agonist
    Rittiner, Joseph E.
    Korboukh, Ilia
    Hull-Ryde, Emily A.
    Jin, Jian
    Janzen, William P.
    Frye, Stephen V.
    Zylka, Mark J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (08) : 5301 - 5309
  • [25] Adenosine receptors and cardiovascular diseaseThe adenosine-1 receptor (A1) and A1 selective ligands
    E. S. Hayes
    Cardiovascular Toxicology, 2003, 3 (1) : 71 - 88
  • [26] Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells
    Shearer, TW
    Crosson, CE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (09) : 3016 - 3020
  • [27] The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation
    Peeters, M. C.
    Wisse, L. E.
    Dinaj, A.
    Vroling, B.
    Vriend, G.
    IJzerman, A. P.
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (01) : 76 - 87
  • [28] Allosteric modulation of the rat adenosine A1 receptor:: Differential effects on agonist and antagonist binding
    Kourounakis, AP
    Visser, C
    de Groote, M
    IJzerman, AP
    DRUG DEVELOPMENT RESEARCH, 2000, 51 (04) : 207 - 215
  • [29] Insulin-induced modulation of agonist action at the human adenosine A1 receptor in CHO cells expressing both insulin and human adenosine A1 receptors
    Presland, JP
    Davidson, J
    McDonnell, JA
    Hill, SJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 : U44 - U44
  • [30] Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteins
    Uustare, Ain
    Reinart, Reet
    Rinken, Ago
    NEUROSCIENCE LETTERS, 2006, 406 (03) : 169 - 173